Who we are

TransAlgae, an Israeli biotech company, has developed a breakthrough technology, using genetically engineered algae as the vehicle to orally deliver therapeutic drugs such as vaccines and insecticides in their intact and functional form for Human Pharma, Animal Health and Crop Protection.

​

TransAlgae's R&D center is located in the Rehovot Science Park and has the following platform units:

Our teams are multi-disciplinary and include experts in algae physiology, genetic engineering, molecular biology, biochemistry and bio-production.